RxDoctor Payments DataLook up a doctor →

Nekea Franklin

Nurse Practitioner · Wayne, MINPI 1659710861

Payments from drug & device makers

$17,843in general payments, 2019–2025

Across 878 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$4K
  • AbbVie$3K
  • Bristol Myers Squibb$1K
  • Eisai Inc.$944
  • SK Life Science, Inc.$847
  • Amgen$625
  • plus $7K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biohaven Pharmaceuticals, Inc.19$4,133
AbbVie(2 entities)262$2,989
Bristol Myers Squibb73$1,094
Eisai Inc.57$944
SK Life Science, Inc.41$847
Amgen(2 entities)39$625
Catalyst Pharmaceuticals, Inc.32$571
Supernus Pharmaceuticals, Inc.29$481
Lundbeck LLC17$387
Jazz Pharmaceuticals Inc.18$372
UCB, Inc.27$370
Argenx US, Inc.19$366
Genentech USA, Inc.19$362
Sanofi13$318
Neurelis, Inc.16$307
Amneal Pharmaceuticals LLC15$301
Neurocrine Biosciences, Inc.14$284
Novartis14$253
Biohaven Pharmaceutical Holding Company Ltd.20$186
Sunovion Pharmaceuticals Inc.13$185
Merz Pharmaceuticals, LLC7$167
Biogen9$164
Otsuka America Pharmaceutical, Inc.2$142
ANI Pharmaceuticals, Inc.6$134
Ipsen Biopharmaceuticals, Inc6$133
AstraZeneca4$127
Alnylam Pharmaceuticals Inc.6$111
Teva Pharmaceuticals USA, Inc.5$105
Acadia Pharmaceuticals Inc5$101
Pfizer6$98
CSL Behring5$96
Upsher-smith Laboratories LLC5$87
EMD Serono, Inc.4$86
Tanabe Pharma America, Inc.4$77
E.r. Squibb & Sons, L.L.C.4$76
Johnson & Johnson3$68
Harmony Biosciences LLC3$65
Bausch Health US, LLC4$63
Lilly USA, LLC3$60
Sumitomo Pharma America, Inc.7$59
Takeda Pharmaceuticals U.S.A., Inc.2$58
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$54
Orphalan Inc1$38
Revance Therapeutics, Inc.1$37
Arbor Pharmaceuticals, Inc.2$34
Avion Pharmaceuticals2$31
Alfasigma USA, Inc.2$28
Kyowa Kirin, Inc.1$26
Idorsia Pharmaceuticals US Inc1$22
TG Therapeutics, Inc.1$21
Aprecia Pharmaceuticals, LLC1$17
Axsome Therapeutics, Inc.1$16
Vanda Pharmaceuticals Inc.1$14
Grifols USA, LLC1$14
Mallinckrodt Hospital Products Inc.1$14
Endo Pharmaceuticals Inc.1$14
GRT US Holding, Inc.1$13

How this compares

$17,843 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan →

Medicare billing

Part B allowed, 2024
$5,967
Medicare patients
23
Services billed
439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Wayne

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →